Articles published by BridgeBio Pharma, Inc.
BridgeBio to Participate in November and December Investor Conferences
November 09, 2026
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
BridgeBio and Community Partners Launch Nationwide ATTR-CM Education Effort Ahead of World Amyloidosis Day
October 05, 2026
Via GlobeNewswire
Tickers
BBIO
Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening
September 23, 2026
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
BridgeBio to Participate in September Investor Conferences
September 01, 2026
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO
Via GlobeNewswire
Tickers
BBIO